NEW YORK, Oct. 18 – Toshiba has entered the biochip arena by developing a DNA chip that it says can help researchers develop individual treatments for patients with hepatitis C, the company said on Thursday.
The company said it planned to start marketing its pilot SNP-detection chip in fiscal 2002, which kicks off in April.